{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:14:58Z","timestamp":1783606498273,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10157-026-02850-9","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:25:05Z","timestamp":1774275905000},"page":"757-766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Distinct clinicopathological features of IgA nephropathy associated with Crohn\u2019s disease: comparison with ulcerative colitis and non-IBD IgA nephropathy"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5234-4845","authenticated-orcid":false,"given":"Akihiro","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaya","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Haruhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"5","key":"2850_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I. Epidemiology of IgA nephropathy: A global perspective. Semin Nephrol. 2018;38(5):435\u201342.","journal-title":"Semin Nephrol"},{"issue":"8","key":"2850_CR2","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.34067\/KID.0000000000000165","volume":"4","author":"K Kiryluk","year":"2023","unstructured":"Kiryluk K, Freedberg DE, Radhakrishnan J, et al. Global incidence of IgA nephropathy by race and ethnicity: A systematic review. Kidney360. 2023;4(8):1112\u201322.","journal-title":"Kidney360."},{"issue":"4","key":"2850_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0272-6386(97)90333-4","volume":"29","author":"A Koyama","year":"1997","unstructured":"Koyama A, Igarashi M, Kobayashi M. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis. 1997;29(4):526\u201332 (Research Group on Progressive Renal Diseases).","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2850_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0272-6386(12)80284-8","volume":"18","author":"E Alamartine","year":"1991","unstructured":"Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis. 1991;18(1):12\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2850_CR5","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.34067\/KID.0002382022","volume":"3","author":"L Sanchez-Russo","year":"2022","unstructured":"Sanchez-Russo L, Rajasekaran A, Bin S, Faith J, Cravedi P. The gut and kidney crosstalk in immunoglobulin A nephropathy. Kidney360. 2022;3(9):1630\u20139.","journal-title":"Kidney360"},{"issue":"8","key":"2850_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.34067\/KID.0002972021","volume":"2","author":"Y Suzuki","year":"2021","unstructured":"Suzuki Y, Monteiro RC, Coppo R, Suzuki H. The phenotypic difference of IgA nephropathy and its race\/gender-dependent molecular mechanisms. Kidney360. 2021;2(8):1339\u201348.","journal-title":"Kidney360"},{"issue":"4","key":"2850_CR7","first-page":"347","volume":"4","author":"M Chiba","year":"2021","unstructured":"Chiba M, Morita N, Nakamura A, Tsuji K, Harashima E. Increased incidence of inflammatory bowel disease in association with dietary transition (Westernization) in Japan. JMA J. 2021;4(4):347\u201357.","journal-title":"JMA J"},{"issue":"1","key":"2850_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12882-022-02883-8","volume":"23","author":"Z Yang","year":"2022","unstructured":"Yang Z, Xu X, Dong Y, Zhang Y. The pathological and outcome characteristics of renal lesions in Crohn\u2019s disease. BMC Nephrol. 2022;23(1):256. https:\/\/doi.org\/10.1186\/s12882-022-02883-8.","journal-title":"BMC Nephrol"},{"issue":"5","key":"2850_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ckj\/sfz004","volume":"12","author":"J Pohjonen","year":"2019","unstructured":"Pohjonen J, Nurmi R, Metso M, et al. Inflammatory bowel disease in patients undergoing renal biopsies. Clin Kidney J. 2019;12(5):645\u201351.","journal-title":"Clin Kidney J"},{"issue":"2","key":"2850_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2215\/CJN.04660513","volume":"9","author":"JM Ambruzs","year":"2014","unstructured":"Ambruzs JM, Walker PD, Larsen CP. The histopathologic spectrum of kidney biopsies in patients with inflammatory bowel disease. Clin J Am Soc Nephrol. 2014;9(2):265\u201370.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2850_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ekir.2023.11.011","volume":"9","author":"F Yandian","year":"2024","unstructured":"Yandian F, Caravaca-Font\u00e1n F, Herrera Hernandez LP, Soler MJ, Sethi S, Fervenza FC. Kidney diseases associated with inflammatory bowel disease: Impact of chronic histologic damage, treatments, and outcomes. Kidney Int Rep. 2024;9(2):383\u201394.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"2850_CR12","doi-asserted-by":"publisher","first-page":"704","DOI":"10.2215\/CJN.0000000000000457","volume":"19","author":"T Nakayama","year":"2024","unstructured":"Nakayama T, Kaneko H, Okada A, et al. Association of inflammatory bowel disease with incident IGA nephropathy. Clin J Am Soc Nephrol. 2024;19(6):704\u201311.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2850_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s13730-023-00836-0","volume":"13","author":"A Shimizu","year":"2024","unstructured":"Shimizu A, Tsuboi N, Haruhara K, et al. Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-\u03b1 antibody drugs for Crohn\u2019s disease: Three case reports and literature review. CEN Case Rep. 2024;13(4):249\u201357.","journal-title":"CEN Case Rep"},{"issue":"1","key":"2850_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s10157-018-1657-0","volume":"23","author":"H Okonogi","year":"2019","unstructured":"Okonogi H, Kawamura T, Joh K, et al. A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity. Clin Exp Nephrol. 2019;23(1):16\u201325.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2850_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: An update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014\u201321.","journal-title":"Kidney Int"},{"issue":"2","key":"2850_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5301\/jn.5000151","volume":"26","author":"T Kawamura","year":"2013","unstructured":"Kawamura T, Joh K, Okonogi H, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: Emphasis on end-stage renal disease. J Nephrol. 2013;26(2):350\u20137.","journal-title":"J Nephrol"},{"issue":"8","key":"2850_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/ndt\/gfv221","volume":"30","author":"J Yasutake","year":"2015","unstructured":"Yasutake J, Suzuki Y, Suzuki H, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30(8):1315\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2850_CR18","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48(3):452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2850_CR19","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00535-025-02295-z","volume":"60","author":"A Tsutsui","year":"2025","unstructured":"Tsutsui A, Murakami Y, Nishiwaki Y, et al. Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn\u2019s Disease in Japan in 2023. J Gastroenterol. 2025;60(12):1513\u201322.","journal-title":"J Gastroenterol"},{"issue":"3","key":"2850_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0016-5085(93)91009-7","volume":"104","author":"H Toyoda","year":"1993","unstructured":"Toyoda H, Wang SJ, Yang HY, et al. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993;104(3):741\u20138.","journal-title":"Gastroenterology"},{"issue":"10","key":"2850_CR21","first-page":"3607","volume":"26","author":"J Yuan","year":"2022","unstructured":"Yuan J, Wang Z, Wang YP. Identification of common key genes associated with Crohn\u2019s Disease and IgA nephropathy. Eur Rev Med Pharmacol Sci. 2022;26(10):3607\u201320.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"2850_CR22","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk K, Li Y, Scolari F, et al. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014;46(11):1187\u201396.","journal-title":"Nat Genet"},{"issue":"6","key":"2850_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002765","volume":"8","author":"K Kiryluk","year":"2012","unstructured":"Kiryluk K, Li Y, Sanna-Cherchi S, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6):e1002765. https:\/\/doi.org\/10.1371\/journal.pgen.1002765.","journal-title":"PLoS Genet"},{"issue":"9","key":"2850_CR24","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ibd.22876","volume":"18","author":"T Inoue","year":"2012","unstructured":"Inoue T, Iijima H, Tajiri M, et al. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn\u2019s Disease. Inflamm Bowel Dis. 2012;18(9):1723\u201334.","journal-title":"Inflamm Bowel Dis"},{"key":"2850_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105256","volume":"106","author":"Y Kinashi","year":"2024","unstructured":"Kinashi Y, Tanaka K, Kimura S, et al. Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice. EBioMedicine. 2024;106:105256. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105256.","journal-title":"EBioMedicine"},{"key":"2850_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.904401","volume":"12","author":"S Han","year":"2022","unstructured":"Han S, Shang L, Lu Y, Wang Y. Gut microbiome characteristics in IgA nephropathy: qualitative and quantitative analysis from observational studies. Front Cell Infect Microbiol. 2022;12:904401. https:\/\/doi.org\/10.3389\/fcimb.2022.904401.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2850_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.34067\/KID.0000132021","volume":"2","author":"NB Shah","year":"2021","unstructured":"Shah NB, Nigwekar SU, Kalim S, et al. The gut and blood microbiome in IgA nephropathy and healthy controls. Kidney360. 2021;2(8):1261\u201374.","journal-title":"Kidney360"},{"issue":"4","key":"2850_CR28","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","volume":"14","author":"UM M\u00f6rbe","year":"2021","unstructured":"M\u00f6rbe UM, J\u00f8rgensen PB, Fenton TM, et al. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function. Mucosal Immunol. 2021;14(4):793\u2013802.","journal-title":"Mucosal Immunol"},{"issue":"3","key":"2850_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","volume":"52","author":"TM Fenton","year":"2020","unstructured":"Fenton TM, J\u00f8rgensen PB, Niss K, et al. Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity. Immunity. 2020;52(3):557\u201370.","journal-title":"Immunity"},{"issue":"2","key":"2850_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s13730-024-00943-6","volume":"14","author":"N Alghamdi","year":"2025","unstructured":"Alghamdi N, Alshehri F, Alhazza S, et al. Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn\u2019s disease: A case report. CEN Case Rep. 2025;14(2):266\u201370.","journal-title":"CEN Case Rep"},{"issue":"11","key":"2850_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/1751-2980.13233","volume":"24","author":"WW Zheng","year":"2023","unstructured":"Zheng WW, Zhou Q, Xue ML, et al. Association between inflammatory bowel disease, nephrolithiasis, tubulointerstitial nephritis, and chronic kidney disease: A propensity score-matched analysis of US nationwide inpatient sample 2016\u20132018. J Dig Dis. 2023;24(11):572\u201383.","journal-title":"J Dig Dis"},{"issue":"3","key":"2850_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2036.2001.00940.x","volume":"15","author":"KR Herrlinger","year":"2001","unstructured":"Herrlinger KR, Noftz MK, Fellermann K, Schmidt K, Steinhoff J, Stange EF. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use. Aliment Pharmacol Ther. 2001;15(3):363\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2850_CR33","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3748\/wjg.v12.i5.739","volume":"12","author":"AC Poulou","year":"2006","unstructured":"Poulou AC, Goumas KE, Dandakis DC. Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol. 2006;12(5):739\u201346.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2850_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01504-6","volume":"8","author":"DC Baumgart","year":"2025","unstructured":"Baumgart DC, Cheng CH, Du TX, et al. Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn\u2019s disease and ulcerative colitis. NPJ Digit Med. 2025;8(1):209. https:\/\/doi.org\/10.1038\/s41746-025-01504-6.","journal-title":"NPJ Digit Med"},{"issue":"1","key":"2850_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-40624-5","volume":"13","author":"T Taida","year":"2023","unstructured":"Taida T, Ohta Y, Kato J, et al. Treatment strategy changes for inflammatory bowel diseases in biologic era: results from a multicenter cohort in Japan, Far East 1000. Sci Rep. 2023;13(1):13555. https:\/\/doi.org\/10.1038\/s41598-023-40624-5.","journal-title":"Sci Rep"},{"issue":"3","key":"2850_CR36","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfaa378","volume":"37","author":"N Joher","year":"2022","unstructured":"Joher N, Gosset C, Guerrot D, et al. Immunoglobulin A nephropathy in association with inflammatory bowel diseases: results from a national study and systematic literature review. Nephrol Dial Transplant. 2022;37(3):531\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2850_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103332","volume":"22","author":"L De Stefano","year":"2023","unstructured":"De Stefano L, Pallavicini FB, Mauric E, et al. Tumor necrosis factor-\u03b1 inhibitor-related autoimmune disorders. Autoimmun Rev. 2023;22(7):103332. https:\/\/doi.org\/10.1016\/j.autrev.2023.103332.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"2850_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10157-018-1665-0","volume":"23","author":"J Ruszkowski","year":"2019","unstructured":"Ruszkowski J, Lisowska KA, Pindel M, Heleniak Z, D\u0119bska-\u015alizie\u0144 A, Witkowski JM. T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target. Clin Exp Nephrol. 2019;23(3):291\u2013303.","journal-title":"Clin Exp Nephrol"},{"key":"2850_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104835","volume":"158","author":"M Leppkes","year":"2020","unstructured":"Leppkes M, Neurath MF. Cytokines in inflammatory bowel diseases - update 2020. Pharmacol Res. 2020;158:104835. https:\/\/doi.org\/10.1016\/j.phrs.2020.104835.","journal-title":"Pharmacol Res"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02850-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02850-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:09:36Z","timestamp":1776424176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02850-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["2850"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02850-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.H. reports receiving a research grant from the Takeda Science Foundation. All the other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and Ethical Guidelines for Medical and Biological Research Involving Human Subjects. The Institutional Review Board of the Jikei University School of Medicine approved the study protocol (36\u2013150[12259]). Informed consent was obtained from all participants through an opt-out procedure, and all individuals were given the opportunity to ask questions and discuss the study prior to inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}